{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:14:06Z","timestamp":1788668046641,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.blre.2026.101388","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:26:21Z","timestamp":1773188781000},"page":"101388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Platelet transfusion guidelines for thrombocytopenic patients in non-surgical and non-traumatic care settings: A systematic review and methodological quality assessment"],"prefix":"10.1016","volume":"77","author":[{"given":"Yana","family":"Criel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik B.","family":"Feys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmy","family":"De Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Vandekerckhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Devos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Van Remoortel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2026.101388_bb0005","series-title":"Platelet Transfusion","author":"Agarwal","year":"2024"},{"key":"10.1016\/j.blre.2026.101388_bb0010","unstructured":"Jinna S, Khandhar PB. Thrombocytopenia. StatPearls 2023."},{"key":"10.1016\/j.blre.2026.101388_bb0015","series-title":"Hemostasis Management of the Pediatric Surgical Patient","first-page":"3","article-title":"Mechanisms of hemostatis","author":"Haimed","year":"2024"},{"key":"10.1016\/j.blre.2026.101388_bb0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/tme.12155","article-title":"Why has demand for platelet components increased? A review","volume":"24","author":"Estcourt","year":"2014","journal-title":"Transfus Med"},{"issue":"4","key":"10.1016\/j.blre.2026.101388_bb0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/tme.12126","article-title":"Where did platelets go in 2012? A survey of platelet transfusion practice in the north of England","volume":"24","author":"Charlton","year":"2014","journal-title":"Transfus Med"},{"issue":"48","key":"10.1016\/j.blre.2026.101388_bb0030","first-page":"809","article-title":"Platelet transfusion in hematology, oncology and surgery","volume":"111","author":"Wandt","year":"2014","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"10.1016\/j.blre.2026.101388_bb0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/vox.12494","article-title":"Effect of storage time of platelet products on clinical outcomes after transfusion: a systematic review and meta-analyses","volume":"112","author":"Kreuger","year":"2017","journal-title":"Vox Sang"},{"issue":"6","key":"10.1016\/j.blre.2026.101388_bb0040","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000522659","article-title":"Transparency on platelet transfusion in routine cancer care: the key for optimal blood usage","volume":"45","author":"Berger","year":"2022","journal-title":"Oncol Res Treat"},{"issue":"4","key":"10.1016\/j.blre.2026.101388_bb0045","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1423-0410.2012.01627.x","article-title":"Platelet transfusion in haematology patients: are we using them appropriately?","volume":"103","author":"Estcourt","year":"2012","journal-title":"Vox Sang"},{"issue":"1","key":"10.1016\/j.blre.2026.101388_bb0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/vox.12550","article-title":"Audit of appropriate use of platelet transfusions: validation of adjudication criteria","volume":"113","author":"Etchells","year":"2018","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2026.101388_bb0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/bjh.19158","article-title":"Harnessing the potential of data-driven strategies to optimize transfusion practice","volume":"204","author":"Evans","year":"2023","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.blre.2026.101388_bb0060","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/trf.12918","article-title":"Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012","volume":"55","author":"Harvey","year":"2015","journal-title":"Transfusion"},{"issue":"24","key":"10.1016\/j.blre.2026.101388_bb0065","first-page":"1","article-title":"Incidence and severity of adverse effects related to platelet transfusion: a narrative review of the literature and the recent hemovigilance data of Japan","volume":"6","author":"Sato","year":"2021","journal-title":"Ann Blood"},{"issue":"6","key":"10.1016\/j.blre.2026.101388_bb0070","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1537-2995.2009.02128.x","article-title":"Analysis of transfusion reactions associated with prestorage-pooled platelet components","volume":"49","author":"Tormey","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2026.101388_bb0075","series-title":"Supporting Patient Blood Management (PBM) in the EU \u2013 A Practical Implementation Guide for Hospitals","author":"European Commission: Consumers, Health, Agriculture and Food Executive Agency","year":"2017"},{"key":"10.1016\/j.blre.2026.101388_bb0080","series-title":"Clinical Pratice Guidelines: Directions for a New Program. Committee to Advise the Public Health Service on Clinical Practice Guidelines","author":"Field","year":"2019"},{"issue":"3","key":"10.1016\/j.blre.2026.101388_bb0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.14423","article-title":"Guidelines for the use of platelet transfusions","volume":"176","author":"Estcourt","year":"2017","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.blre.2026.101388_bb0090","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/trf.16257","article-title":"Quality of evidence-based guidelines for platelet transfusion and use: a systematic review","volume":"61","author":"Al-Riyami","year":"2021","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.blre.2026.101388_bb0095","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/vox.13387","article-title":"Systematic reviews on platelet transfusion: is there unnecessary duplication of effort? A scoping review","volume":"118","author":"Avau","year":"2023","journal-title":"Vox Sang"},{"issue":"1","key":"10.1016\/j.blre.2026.101388_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.XEB.0000444637.88465.a3","article-title":"Use of evidence-based practice in an aid organisation: a proposal to deal with the variety in terminology and methodology","volume":"12","author":"De Buck","year":"2014","journal-title":"Int J Evid Based Healthc"},{"key":"10.1016\/j.blre.2026.101388_bb0105","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"16","key":"10.1016\/j.blre.2026.101388_bb0110","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1503\/cmaj.140547","article-title":"The validity of recommendations from clinical guidelines: a survival analysis","volume":"186","author":"Garcia","year":"2014","journal-title":"CMAJ"},{"issue":"12","key":"10.1016\/j.blre.2026.101388_bb0115","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/jama.286.12.1461","article-title":"Validity of the Agency for Healthcare Research and Quality clinical practice guidelines","volume":"286","author":"Shekelle","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2026.101388_bb0120","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in healthcare","volume":"182","author":"Brouwers","year":"2010","journal-title":"Can Med Assoc J"},{"issue":"1","key":"10.1016\/j.blre.2026.101388_bb0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjh.19414","article-title":"Cancer-associated venous thrombosis in adults (second edition): a British Society for Haematology guideline","volume":"205","author":"Alikhan","year":"2024","journal-title":"Br J Haematol"},{"issue":"22","key":"10.1016\/j.blre.2026.101388_bb0130","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.blre.2026.101388_bb0135","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3747\/co.22.2587","article-title":"Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment","volume":"22","author":"Easaw","year":"2015","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.blre.2026.101388_bb0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/bjh.14675","article-title":"Erratum","volume":"177","author":"Estcourt","year":"2017","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.blre.2026.101388_bb0145","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000750","article-title":"EHA guidelines on Management of Antithrombotic Treatments in thrombocytopenic patients with cancer","volume":"6","author":"Falanga","year":"2022","journal-title":"HemaSphere"},{"issue":"3","key":"10.1016\/j.blre.2026.101388_bb0150","doi-asserted-by":"crossref","first-page":"cxvi","DOI":"10.1177\/23969873211030842","article-title":"European stroke organization interim expert opinion on cerebral venous thrombosis occurring after SARS-CoV-2 vaccination","volume":"6","author":"Ferro","year":"2021","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.blre.2026.101388_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2024.102860","article-title":"Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP)","volume":"108","author":"Guarina","year":"2024","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.blre.2026.101388_bb0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejim.2022.02.020","article-title":"Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence","volume":"100","author":"Jim\u00e9nez-Fonseca","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.blre.2026.101388_bb0165","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00277-019-03622-0","article-title":"Management of sepsis in neutropenic cancer patients: 2018 guidelines from the infectious diseases working party (AGIHO) and intensive care working party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO)","volume":"98","author":"Kochanek","year":"2019","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.blre.2026.101388_bb0170","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjh.19236","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia: a British Society for Haematology guideline","volume":"204","author":"Kulasekararaj","year":"2024","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.blre.2026.101388_bb0175","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bjh.15813","article-title":"Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach","volume":"185","author":"Lieberman","year":"2019","journal-title":"Br J Haematol"},{"issue":"13 Suppl 1 1S","key":"10.1016\/j.blre.2026.101388_bb0180","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1097\/PCC.0000000000002857","article-title":"Plasma and platelet transfusion strategies in critically ill children with malignancy, acute liver failure and\/or liver transplantation, or sepsis: from the transfusion and Anemia EXpertise initiative-control\/avoidance of bleeding","volume":"23","author":"Lieberman","year":"2022","journal-title":"Pediatr Crit Care Med"},{"issue":"12","key":"10.1016\/j.blre.2026.101388_bb0185","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.bbmt.2017.08.014","volume":"23","author":"Mahadeo","year":"2017","journal-title":"Biol Blood Marrow Transpl"},{"issue":"10","key":"10.1016\/j.blre.2026.101388_bb0190","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00134-021-06508-w","article-title":"Critically ill cancer patient\u2019s resuscitation: a Belgian\/French societies\u2019 consensus conference","volume":"47","author":"Meert","year":"2021","journal-title":"Intensive Care Med"},{"issue":"7","key":"10.1016\/j.blre.2026.101388_bb0195","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.2025.7529","article-title":"Platelet transfusion: 2025 AABB and ICTMG international clinical practice guidelines","volume":"334","author":"Metcalf","year":"2025","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.blre.2026.101388_bb0200","first-page":"176","article-title":"Diagnosis and clinical management of thrombotic thrombocytopenic purpura (TTP): a consensus statement from the TTP Catalan group","volume":"22","author":"Mu\u00f1oz","year":"2024","journal-title":"Blood Transfus"},{"issue":"3","key":"10.1016\/j.blre.2026.101388_bb0205","first-page":"171","article-title":"Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus","volume":"17","author":"Napolitano","year":"2019","journal-title":"Blood Transfus"},{"issue":"1","key":"10.1016\/j.blre.2026.101388_bb0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/PCC.0000000000002851","article-title":"Executive summary of recommendations and expert consensus for plasma and platelet transfusion practice in critically ill children: from the transfusion and Anemia EXpertise initiative-control\/avoidance of bleeding (TAXI-CAB)","volume":"23","author":"Nellis","year":"2022","journal-title":"Pediatr Crit Care Med"},{"issue":"5","key":"10.1016\/j.blre.2026.101388_bb0215","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjh.14233","article-title":"Guidelines on transfusion for fetuses, neonates and older children","volume":"175","author":"New","year":"2016","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.blre.2026.101388_bb0220","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/bjh.17109","article-title":"British Society for Haematology guidelines on transfusion for fetuses, neonates and older children (Br J Haematol. 2016;175:784-828). Addendum august 2020","volume":"191","author":"New","year":"2020","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.blre.2026.101388_bb0225","article-title":"The ASH-ASPHO choosing wisely campaign: 5 hematologic tests and treatments to question","volume":"68","author":"O\u2019Brien","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"22","key":"10.1016\/j.blre.2026.101388_bb0230","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.blre.2026.101388_bb0235","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.blre.2026.101388_bb0240","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1200\/JCO.2017.76.1734","article-title":"Platelet transfusion for patients with cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"36","author":"Schiffer","year":"2018","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.blre.2026.101388_bb0245","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1200\/JCO.2017.18.0088","article-title":"Erratum","volume":"36","author":"Schiffer","year":"2018","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.blre.2026.101388_bb0250","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1182\/bloodadvances.2020001920","article-title":"American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults","volume":"4","author":"Sekeres","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.blre.2026.101388_bb0255","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/bjh.15112","article-title":"BSH guideline: management of thrombotic and haemostatic issues in paediatric malignancy","volume":"180","author":"Sibson","year":"2018","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.blre.2026.101388_bb0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jtha.2023.09.031","article-title":"Management of chemotherapy-induced thrombocytopenia: guidance from the ISTH subcommittee on hemostasis and malignancy","volume":"22","author":"Soff","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.blre.2026.101388_bb0265","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1160\/TH15-09-0740","article-title":"Supportive management strategies for disseminated intravascular coagulation: an international consensus","volume":"115","author":"Squizzato","year":"2016","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.blre.2026.101388_bb0270","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00134-019-05884-8","article-title":"Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine","volume":"46","author":"Vlaar","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.blre.2026.101388_bb0275","series-title":"Guidance for Clinical Case Management of Thrombosis With Thrombocytopenia Syndrome (TTS) Following Vaccination to Prevent Coronavirus Disease (COVID-19)","author":"WHO Guidelines Approved by the Guidelines Review Committee","year":"2023"},{"key":"10.1016\/j.blre.2026.101388_bb0280","doi-asserted-by":"crossref","unstructured":"Yomayusa N, Acevedo J, Abello Polo V, Izaguirre R, Ram\u00edrez C, Solano MH, et al. Recommendations for the diagnosis and management of persons with suspected vaccine-induced immune thrombotic thrombocytopenia (VITT). Infection 2021;26(1):3\u201310.","DOI":"10.22354\/in.v26i1.987"},{"issue":"2","key":"10.1016\/j.blre.2026.101388_bb0285","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropr Med"},{"issue":"3","key":"10.1016\/j.blre.2026.101388_bb0290","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M14-1589","article-title":"Platelet transfusion: a clinical practice guideline from the AABB","volume":"162","author":"Kaufman","year":"2015","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.blre.2026.101388_bb0295","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines fort he diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick","year":"2016","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.blre.2026.101388_bb0300","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.tmrv.2014.11.004","article-title":"Guidance on platelet transfusion for patients with hypoproliferative thrombocytopenia","volume":"29","author":"Nahirniak","year":"2015","journal-title":"Transfus Med Rev"},{"issue":"5","key":"10.1016\/j.blre.2026.101388_bb0305","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/M20-7884","article-title":"Clinical practice guidelines registry: toward reducing duplication, improving collaboration and increasing transparency","volume":"174","author":"Chen","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2026.101388_bb0310","series-title":"GRADE Handbook. Grading of Recommendations Assessment, Development and Evaluation","author":"Schumemann","year":"2013"},{"key":"10.1016\/j.blre.2026.101388_bb0315","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12874-025-02534-0","article-title":"Defining expert opinion in clinical guidelines: insights from 98 scientific societies \u2013 a methodological study","volume":"25","author":"Nagavci","year":"2025","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"10.1016\/j.blre.2026.101388_bb0320","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1097\/MLR.0b013e3182a51b3d","article-title":"Out of context: clinical practice guidelines and patients with multiple chronic conditions: a systematic review","volume":"52","author":"Wyatt","year":"2014","journal-title":"Med Care"},{"issue":"Suppl. 3","key":"10.1016\/j.blre.2026.101388_bb0325","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.injury.2022.01.047","article-title":"Clinical practice guidelines: the good, the bad, and the ugly","volume":"54","author":"Guerra-Farfan","year":"2023","journal-title":"Injury"},{"issue":"1","key":"10.1016\/j.blre.2026.101388_bb0330","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood-2003-03-0940","article-title":"Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness","volume":"103","author":"Seftel","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2026.101388_bb0335","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1182\/hematology.2020000135","article-title":"Does ABO and RhD matching matter for platelet transfusion?","volume":"2020","author":"Dunbar","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"5","key":"10.1016\/j.blre.2026.101388_bb0340","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1213\/ANE.0000000000006918","article-title":"Platelet transfusion: the good, the bad and the ugly","volume":"138","author":"Blumberg","year":"2024","journal-title":"Anesth Analg"},{"key":"10.1016\/j.blre.2026.101388_bb0345","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1213\/ANE.0000000000006742","article-title":"Special communication: response to \u201censuring a reliable platelet supply in the United States\u201d","volume":"138","author":"Burns","year":"2023","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.blre.2026.101388_bb0350","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/trf.18277","article-title":"The clinical use of platelet transfusions: a systematic literature review and meta-analysis on behalf of the international collaboration for transfusion medicine guidelines","volume":"65","author":"Jug","year":"2025","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2026.101388_bb0355","series-title":"Supporting Patient Blood Management (PBM) in the EU \u2013 A practical implementation guide for hospitals","author":"Gombotz","year":"2017"},{"issue":"5","key":"10.1016\/j.blre.2026.101388_bb0360","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/trf.18234","article-title":"How do we leverage implementation science to support and accelerate uptake of clinical practice guidelines in transfusion medicine","volume":"65","author":"Crawshaw","year":"2025","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.blre.2026.101388_bb0365","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/hematology.2019000062","article-title":"Clinical decision support and improved blood use in patient blood management","volume":"2019","author":"Goodnough","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"10.1016\/j.blre.2026.101388_bb0370","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tmrv.2014.10.002","article-title":"The impact of electronic decision support on transfusion practice: a systematic review","volume":"29","author":"Hibbs","year":"2015","journal-title":"Transfus Med Rev"},{"issue":"1","key":"10.1016\/j.blre.2026.101388_bb0375","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/vox.13132","article-title":"A randomized study of a best practice alert for platelet transfusions","volume":"117","author":"Murphy","year":"2022","journal-title":"Vox Sang"},{"issue":"1","key":"10.1016\/j.blre.2026.101388_bb0380","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12911-022-02045-8","article-title":"Effectiveness of clinical decision support in controlling inappropriate red blood cell and platelet transfusions, speciality specific responses and behavioural change","volume":"22","author":"Atia","year":"2022","journal-title":"BMC Med Inform Decis Mak"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X26000275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X26000275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T03:58:48Z","timestamp":1788667128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X26000275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":76,"alternative-id":["S0268960X26000275"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2026.101388","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet transfusion guidelines for thrombocytopenic patients in non-surgical and non-traumatic care settings: A systematic review and methodological quality assessment","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2026.101388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101388"}}